Brandinium

Trademark search for:

TALECRIS BIOTHERAPEUTICS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2005-01-21 — Application filed
  • 2005-01-31 — Application filed
  • 2005-08-19 — Assigned to examiner
  • 2005-08-29 — Examiners amendment and/or priority action - completed
  • 2005-08-29 — Examiner's amendment/priority action e-mailed
  • 2005-08-30 — Assigned to lie
  • 2005-08-31 — Combined examiner's amendment/priority action entered
  • 2005-11-07 — Teas change of correspondence received
  • 2006-01-23 — Office action issued
  • 2006-01-23 — Correspondence received in law office
  • 2006-01-30 — Teas/email correspondence entered
  • 2006-01-31 — Attorney/dom.rep.revoked and/or appointed
  • 2006-01-31 — Teas revoke/app/change addr of atty/dom rep received
  • 2006-02-07 — Examiners amendment -written
  • 2006-02-07 — Approved for pub - principal register
  • 2006-02-07 — Examiners amendment e-mailed
  • 2006-02-27 — Assigned to lie
  • 2006-02-27 — Law office publication review completed
  • 2006-07-05 — Notice of publication
  • 2006-07-25 — Published for opposition
  • 2006-10-17 — Noa mailed - sou required from applicant
  • 2006-12-27 — Assignment of ownership not updated automatically
  • 2007-04-16 — Sou teas extension received
  • 2007-04-16 — Sou extension 1 filed
  • 2007-04-16 — Sou extension 1 granted
  • 2007-10-17 — Teas statement of use received
  • 2007-10-17 — Use amendment filed
  • 2007-11-02 — Statement of use processing complete
  • 2007-11-27 — Allowed principal register - sou accepted
  • 2008-01-10 — Assigned to lie
  • 2008-01-11 — Law office registration review completed
  • 2008-02-19 — Registered-principal register
  • 2013-07-03 — Automatic update of assignment of ownership
  • 2013-12-02 — Attorney/dom.rep.revoked and/or appointed
  • 2013-12-02 — Registered - sec. 8 (6-yr) & sec. 15 filed
  • 2013-12-02 — Teas section 8 & 15 received
  • 2013-12-02 — Teas revoke/app/change addr of atty/dom rep received
  • 2013-12-12 — Case assigned to post registration paralegal
  • 2013-12-12 — Registered - partial sec. 8 (6-yr) accepted & sec. 15 ack.
  • 2013-12-12 — Notice of acceptance of sec. 8 & 15 - e-mailed
  • 2014-03-05 — Assignment of ownership not updated automatically
  • 2014-06-20 — Attorney/dom.rep.revoked and/or appointed
  • 2014-06-20 — Teas revoke/app/change addr of atty/dom rep received
  • 2017-02-19 — Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  • 2017-02-22 — Assignment of ownership not updated automatically
  • 2018-01-31 — Automatic update of assignment of ownership
  • 2018-09-21 — Cancelled sec. 8 (10-yr)/expired section 9
  • 2018-09-21 — Final status recorded

Owner Information

GRIFOLS THERAPEUTICS LLC
LOS ANGELES , CA
GRIFOLS THERAPEUTICS INC.
RESEARCH TRIANGLE PARK , NC
TALECRIS BIOTHERAPEUTICS, INC.
RESEARCH TRIANGLE PARK , NC
TALECRIS BIOTHERAPEUTICS, INC.
RESEARCH TRIANGLE PARK , NC
TALECRIS BIOTHERAPEUTICS, INC.
RESEARCH TRIANGLE PARK , NC
NPS Biotherapeutics, Inc.
New York , NY

Correspondent

Paul Fields Leason Ellis LLP
One Barker Avenue, Fifth Floor
White Plains, NY 10601
UNITED STATES

Filing Details

Filing Date:
2005-01-21
Status Date:
2018-09-21
Category:
Pharmaceuticals
Filing Year:
2005

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.